RESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA

Clinical trials for RESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA trials appear

Sign up with your email to follow new studies for RESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for tough liver cancer: boosting chemo before surgery

Disease control Recruiting now

This study is testing if adding an immunotherapy drug called durvalumab to standard chemotherapy before surgery helps people with a high-risk type of liver cancer called cholangiocarcinoma. The goal is to shrink the tumor before the operation, potentially making surgery more succ…

Matched conditions: RESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

RESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA

Get alerted when new RESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA trials appear

New hope for tough liver cancer: boosting chemo before surgery